NCT01010295View on ClinicalTrials.gov

A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

May 31, 2012

Conditions

Non-Hodgkin Lymphoma

Interventions

DRUG

doxycycline (tetracycline)

doxycycline 100 mg twice daily for 3 weeks

Trial Locations (6)

6500

IOSI, Bellinzona

20132

Ospedale San Raffaele, Department of Oncology, Milan

Unknown

Hospital del Salvador, Providencia, Santiago

S. Matteo, Pavia

A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia, Reggio Calabria

Hospital Ramon y Cajal, Madrid

All Listed Sponsors

lead

International Extranodal Lymphoma Study Group (IELSG)

OTHER

NCT01010295 - A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae | Biotech Hunter | Biotech Hunter